Found Review: Following the Care Path From Assessment to Refills

A prescription is only one handoff in Found’s weight-management program. A prospective member first completes an assessment, a clinician decides whether treatment is appropriate, and a pharmacy fills the prescription. What happens between those steps depends partly on whether the member uses insurance or pays directly. Found documents both routes, but they involve different visit requirements, costs and pharmacy arrangements—not simply two ways to pay for identical service.

This review follows that care pathway using public documentation consulted October 19, 2026. Found describes an online program offering branded GLP-1 medicines, compounded injections, oral alternatives and app-based support. Its materials explain several useful service responsibilities, including monthly follow-up for compounded tirzepatide and injection education. They leave other operational questions unresolved, particularly pharmacy identities, delivery arrangements, geographic availability and conflicting price conditions. The central question is how clearly each participant’s responsibility is defined before enrollment.

At a glance

Assessment before prescribing: Found says a clinician reviews health history, previous attempts and personal circumstances; a prescription depends on clinical appropriateness.
Sources: [7]
Insurance changes the visit pathway: Insurance-based care requires synchronous video visits, including before each refill; cash-pay care is text-based in most cases.
Sources: [11]
Different pharmacy channels: Found facilitates compounded prescriptions through pharmacy partners; branded prescriptions may use a chosen pharmacy or eligible cash-pay manufacturer channels.
Sources: [7] [8]
Four-week billing: Published plan tables use 28-day billing cycles. Marketing also conditions the lowest advertised compounded prices on a 12-month plan paid upfront.
Sources: [8] [10]
Medication and membership differ: Compounded plans include medication, while branded GLP-1 plans charge separately for the medicine. Applicable laboratory costs are excluded from compounded plans.
Sources: [8]

The first handoff: from assessment to a treating clinician

Found describes itself as an online weight-loss program offering personalized care. Its compounded semaglutide pathway starts with a short health assessment, followed by a clinician’s review of medical history, previous weight-management efforts and practical circumstances. That is an evaluation process, not a promise of a particular prescription. Preparing a medication list and questions about responsibilities is more useful than arriving with only a preferred drug; our guide to preparing for the first consultation explains that distinction.

The platform and treating medical organizations are not interchangeable. Found’s billing consent identifies affiliated groups, including Pippen entities, while Found says every clinician is board-certified and trained in metabolic medicine. Those are provider statements, not independently verified credentials in this review. Before paying, ask which medical group will provide care, which clinician will evaluate you and whom to contact about a clinical concern versus a subscription problem.

Eligibility also varies by offering. The compounded semaglutide page refers to adults who may benefit from weight loss. The compounded tirzepatide page describes adults with obesity or overweight, a BMI of at least 25 and at least one weight-related condition. These are Found’s published descriptions, not individualized eligibility advice or a general rule for every medication. The consulted documentation does not establish a single minimum age or complete admission standard for the entire program.

Sources: [7] [12] [5] [3]

Insurance and cash pay lead to different encounters

Found’s insurance pathway requires synchronous video visits, including before each refill. The visit is billed to insurance, with a copay described as typically around $30, additional to the plan price. Cash-pay care is asynchronous and text-based in most cases, with no separate visit copay. Consequently, a member’s coverage choice affects scheduling as well as spending. Someone choosing insurance should understand the video appointment requirement before assuming refills can be handled entirely through messages.

Found offers a free coverage checker that reports medication-specific coverage, prior-authorization requirements and estimated copays or out-of-pocket costs when available. Using it does not request treatment or produce a prescription. Insurance participation for clinical visits also does not establish coverage for medicine. Found’s consent says members remain responsible for compounded GLP-1 charges and must not submit those amounts to insurance; it separately describes the subscription as a noncovered service.

The consent allows additional billing after an insurance claim is processed. An invoice is due within 15 days, after which the card on file may be charged; an unsuccessful payment brings another 30 days to resolve the balance before subscription termination. Scheduled consultations also carry a $30 missed-visit fee when unattended or canceled with less than 24 hours’ notice. These responsibilities sit alongside, rather than replace, the advertised plan charge.

Sources: [11] [9] [12]

The prescription determines the pharmacy handoff

Found’s documented offerings include compounded semaglutide as a once-weekly subcutaneous injection and compounded tirzepatide as a once-weekly injection. It also advertises branded products and non-GLP-1 oral generics. Found distinguishes medicines approved for obesity from products approved for other conditions that clinicians may prescribe off-label. Its separate “microdosing” page describes compounded injectable semaglutide, but does not establish complete admission criteria or pricing; it also states that compounded GLP-1s are not approved to treat a specific condition.

For compounded care, Found says it partners exclusively with 503A pharmacies and describes patient-specific prescriptions, licensed pharmacists and USP sterile-preparation standards. It also says compounded semaglutide undergoes third-party potency, purity and sterility testing before shipment. The consulted materials do not name those pharmacies or the testing laboratory or provide certificates of analysis. These remain Found’s quality-control claims rather than independently verified findings. Ask for the dispensing pharmacy’s identity and contact information before the shipment stage.

Branded prescriptions follow a different arrangement: Found says members may use a pharmacy of their choice, paying cash or using insurance, or access NovoCare or LillyDirect where eligible. Those manufacturer channels are described as cash-pay only. The branded plan does not include medication cost. Our pharmacy handoff guide offers a framework for confirming who fills the prescription, who answers product questions and which organization handles a fulfillment problem.

Sources: [7] [3] [5] [4] [8]

What the bundled charge covers—and what it does not

Found’s compounded-plan terms list a metabolic assessment, access to medical providers, compounded medication, individual health coaching, app-based lifestyle tools and community access. Applicable labs and branded GLP-1 medicines are excluded. The table below preserves the published insurance and cash-pay rates for both compounded injectables. Although labeled monthly, these amounts are billed every four weeks, or 28 days. The insurance price reflects coverage for clinical care, with possible copays, coinsurance and deductibles—not insurance payment for the compounded medicine.

The first charge can differ from subsequent charges. For new members on a one-month compounded semaglutide plan, the terms list $99 initially and then $199 with insurance, or $179 initially and then $289 cash pay. Compounded tirzepatide is $149 initially and then $289 with insurance, or $219 initially and then $359 cash pay. These introductory offers should not be confused with the similarly low rates attached to longer plans.

There is also an unresolved collection issue: marketing conditions starting prices on 12-month plans paid upfront, while the terms describe four-week billing by plan term. Confirm the actual checkout amount, subsequent charges and covered duration in writing. The branded and oral-generic plans list the same recurring membership schedule: insurance/cash-pay rates of $89/$149, $79/$139, $69/$129 and $49/$99 for one-, three-, six- and 12-month terms. Generics include prescription, medication and membership; branded plans exclude medication. Their listed durations are four, 12, 24 and 48 weeks.

Published compounded-injection rates per 28-day cycle; insurance/cash-pay amounts shown together. Upfront collection terms require confirmation.
Advertised plan term	Compounded semaglutide	Compounded tirzepatide
1 month	$199 insurance / $289 cash	$289 insurance / $359 cash
3 months	$159 insurance / $249 cash	$239 insurance / $309 cash
6 months	$129 insurance / $219 cash	$209 insurance / $289 cash
12 months	$99 insurance / $169 cash	$179 insurance / $239 cash

Sources: [8] [10]

Shipping promises stop short of a delivery specification

Found says an eligible member’s medication will be shipped home after assessment and clinician review, and that most members can start treatment within a week. That is a provider estimate for the overall starting process, not a guaranteed delivery date or a measured transit interval. The consulted documentation does not separate clinical review time, pharmacy preparation, dispatch and arrival. It also does not establish shipping charges, carrier, cold-chain arrangements or medication quantity per package.

Geography needs confirmation at the product level. Found states that compounded medicines are not available in all states, but the consulted geographic modules do not establish a definitive, consistent state list for each medication and care modality. Before enrolling, verify availability for your address, the intended formulation and the chosen payment route. A plan’s stated duration does not itself tell you how many shipments or how much medicine will be supplied.

The delivery handoff should include a clear problem-resolution contact. FDA advises not using an injectable GLP-1 medicine that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. That advice applies independently of a platform’s general shipping estimate. Our guide to warm injectable deliveries explains the distinction between resolving a questionable shipment and trying to judge the product yourself.

Sources: [5] [8] [1]

Follow-up is documented, but response times are not

Found’s compounded tirzepatide page says the care team follows up monthly to review response, make treatment changes where appropriate and address difficulties. Its semaglutide page says the provider explains injection, storage and disposal and allows messaging between visits. Those are meaningful service commitments, but permission to message at any time is not a promise of immediate clinical response. The consulted documentation does not establish a response-time standard or a continuous human clinical service.

The app adds lifestyle and behavioral support, community access and Aimee, described as an AI health companion available 24/7. That round-the-clock availability refers to the AI feature, not necessarily a clinician or coach. Members should ask which channel reaches the prescribing team, how monthly reviews are initiated and whether a delayed appointment can interrupt a refill. Our ongoing-support guide distinguishes access to digital tools from scheduled clinical care.

The broader clinical boundary matters here. FDA does not approve compounded preparations or review them before marketing for safety, effectiveness and quality; nonapproval alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug. NIDDK describes follow-up as considering response and tolerability, not simply continuing payments. Found’s service descriptions and testing claims therefore should not be mistaken for clinical-trial evidence about its compounded products or individual outcomes.

Sources: [3] [7] [10] [1] [2]

Medicare and branded pricing need a separate confirmation

Found’s general offer terms exclude people with government insurance, including Medicare, Medicaid, TriCare and MediCal, from insurance pricing. A separate page nevertheless advertises care for adults ages 65–75 and conditional access to what Found describes as the Medicare GLP-1 Bridge. Found describes that program as running July 1, 2026, through December 31, 2027, outside normal Part D payment flow. The consulted pages do not fully reconcile this pathway with the general exclusion.

According to Found, eligible Part D members with a qualifying prescription may have a $50 monthly medication copay, separate from membership. It says that copay does not count toward the Part D deductible or out-of-pocket maximum and that low-income subsidies do not apply; coverage is not guaranteed. The same page associates $99 semaglutide and $179 tirzepatide starting prices with cash pay and separate membership, unlike other pages. Those figures should not be treated as a reconciled offer.

Branded medication prices also require a product-specific quote. The catalog advertises Ozempic at $1,100 monthly, Wegovy and Zepbound from $650 monthly plus, and Mounjaro at approximately $1,100 monthly, without full supply conditions. Other comparison material advertises lower cash-pay ranges tied to multimonth plans without clearly reconciling presentation or channel. Ask for the exact medicine, route, presentation, pharmacy and membership charge rather than treating any ingredient-level starting price as the complete cost.

Sources: [8] [6] [10] [7] [3]

Leaving the program is another care handoff

Found’s refund language deserves clarification before the first consultation. It lists a full membership refund when cancellation occurs within three days of the original purchase or before completing the first medical consultation. A subsequent sentence says the fee becomes nonrefundable after either event has occurred, making the interaction between those milestones ambiguous. Do not assume the more generous interpretation will govern, particularly when considering a larger upfront payment.

Medication and lab kits are nonreturnable and nonrefundable once dispensed or shipped, even unused. Medical disqualification from all treatment options can support a membership refund, but being unable to receive a preferred medicine does not qualify if other Found options remain available. That distinction matters for someone enrolling specifically to obtain one branded or compounded product: payment does not guarantee that prescription or an automatic refund if it is unsuitable.

Renewal payments are nonrefundable. Found recommends canceling or pausing at least 48 hours before the scheduled renewal to avoid charges. The documentation does not clearly establish the operational cancellation steps or treatment of unused prepaid periods. Before leaving, ask separately about stopping future billing, any refund request, outstanding clinical invoices and continuity of care. Ending a subscription should not be mistaken for individualized instructions about changing medication.

Sources: [8] [2]

Questions & answers

Does Found guarantee a GLP-1 prescription after enrollment?

No. Found describes a clinician evaluation and prescribing only when appropriate. Its refund policy also distinguishes disqualification from every available treatment from inability to receive a preferred medication. If another option remains available, not receiving the GLP-1 you wanted does not automatically qualify for a membership refund. Clarify that boundary before purchasing.

Sources: [7] [8]

Will I need a video visit before every Found refill?

Found says synchronous video visits are required before each refill when using its insurance pathway. Those visits are billed through insurance, with a typical copay around $30 in addition to the plan price. Cash-pay care is text-based in most cases and does not carry a separate visit copay. Confirm which pathway applies before scheduling.

Sources: [11]

Can Found send a branded prescription to my own pharmacy?

Its terms say branded GLP-1 prescriptions may be filled at a pharmacy of your choice using cash or insurance. Eligible members may alternatively use NovoCare or LillyDirect, described as cash-pay-only channels. Medication is billed separately from the branded membership plan, so confirm both the pharmacy price and Found’s charge.

Sources: [8]

Does Found identify its compounded pharmacy before enrollment?

The consulted materials describe 503A pharmacy partnerships but do not identify the individual pharmacies or testing laboratory. They also do not provide certificates of analysis. Ask Found for the pharmacy responsible for your prescription, its contact information and the available product documentation. The public testing description is a provider claim, not independent verification.

Sources: [7]

Is Found’s lowest compounded price available month to month?

Not as an ordinary ongoing one-month rate. Marketing ties the lowest prices to a 12-month plan paid upfront, while terms also describe 28-day billing. New-member one-month discounts are separate introductory offers with higher subsequent charges. Request the initial collection, renewal amount, billing dates and actual covered duration rather than relying on a monthly headline.

Sources: [10] [8]

Does Found’s 24/7 support mean a clinician is always available?

The explicit 24/7 offering is Aimee, Found’s AI health companion. Found also documents care-team messaging between visits and monthly follow-up for compounded tirzepatide, but does not establish immediate human responses. Ask how to reach the prescribing team, what response interval to expect and which contact handles questions about an upcoming refill.

Sources: [10] [7] [3]

Our assessment

Found documents a recognizable care pathway: assessment, clinician review, prescription fulfillment, administration education and ongoing support. Its distinction between insured video visits and mostly text-based cash care is particularly useful, as is the separation between bundled compounded treatment and separately purchased branded medicine. The weaknesses are concentrated at the handoffs: unnamed pharmacy partners, limited delivery specifications, unclear response standards and unresolved billing and Medicare inconsistencies. Before enrolling, obtain a written explanation of the exact product and pharmacy, initial and recurring payments, refill requirements, cancellation process and clinical contact channel. Found’s documentation supports considering it as an online weight-management service, but not assuming that every advertised price or access route applies to the same member.

Visit Found’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

FOLLOW THE EVIDENCE

Research behind treatment claims

Use these studies to assess the type of outcome a treatment claim describes. They did not test this provider or establish results for its products.

SURMOUNT-5: What a Direct Weight-Loss Comparison Can—and Cannot—Tell You About Ongoing Care
Tirzepatide produced greater average weight and waist reductions than semaglutide over 72 weeks. Understanding the trial’s design matters just as much as understanding the difference.
After the Weight Loss: What SURMOUNT-4 Means for Continuity of Care
Randomized tirzepatide withdrawal separates maintaining a treatment effect from finishing a course. Reading its two baselines—and newer maintenance-dose research—shows what the evidence can and cannot tell patients changing care.

Explore the science library →

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Found Review: Following the Care Path From Assessment to Refills

At a glance

01The first handoff: from assessment to a treating clinician

02Insurance and cash pay lead to different encounters

03The prescription determines the pharmacy handoff

04What the bundled charge covers—and what it does not

05Shipping promises stop short of a delivery specification

06Follow-up is documented, but response times are not

07Medicare and branded pricing need a separate confirmation

08Leaving the program is another care handoff